GUIDED THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Guided Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q1 2024.
  • Guided Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $14.8K, a 86.1% decline year-over-year.
  • Guided Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $236K, a 34.3% increase from 2022.
  • Guided Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $176K, a 23% decline from 2021.
  • Guided Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $228K, a 26.5% decline from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $14.8K -$92.2K -86.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $107K +$63.1K +143% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $44K -$18K -29% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q1 2021 $62K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2014 $298K -$132K -30.7% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q3 2013 $130K -$13K -9.09% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-13
Q1 2013 $430K +$232K +117% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q3 2012 $143K +$47K +49% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $152K +$43K +39.5% Apr 1, 2012 Jun 30, 2012 10-Q/A 2012-08-24
Q1 2012 $198K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 $96K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $109K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.